MedTrace Logo

HANSE - Holistic Implementation Study Assessing a Northern German Interdisciplinary Lung Cancer Screening Effort

NCT04913155 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12100

Last updated 2025-10-02

No results posted yet for this study

Summary

The HANSE study is primarily intended as a pilot to provide evidence that a holistic and effective lung cancer screening program can be implemented in Germany and that such a screening program can be integrated in the current infrastructure of certified lung cancer centers.

Conditions

Interventions

RADIATION

Low-dose CT screening

Low-dose computed tomography with lung nodule evaluation (LungRADS1.1, highrisk score group), randomized reporting of coronary artery calcium score and emphysema score

Sponsors & Collaborators

  • LungenClinic Grosshansdorf

    collaborator OTHER

  • University Hospital Schleswig-Holstein

    collaborator OTHER

  • German Center for Lung Research

    collaborator OTHER

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Jens Vogel-Claussen, Prof. Dr. · Hannover Medical School

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-20
Primary Completion
2024-03-01
Completion
2028-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04913155 on ClinicalTrials.gov